
### [MONDO:0017595](http://purl.obolibrary.org/obo/MONDO_0017595)
**Label:** aggressive b-cell non-Hodgkin lymphoma

**Subclasses:** [MONDO:0015818](http://purl.obolibrary.org/obo/MONDO_0015818) (aggressive primary cutaneous b-cell lymphoma), [MONDO:0007243](http://purl.obolibrary.org/obo/MONDO_0007243) (Burkitts lymphoma), [MONDO:0018905](http://purl.obolibrary.org/obo/MONDO_0018905) (diffuse large b-cell lymphoma), [MONDO:0020511](http://purl.obolibrary.org/obo/MONDO_0020511) (precursor b-cell acute lymphoblastic leukemia), 

**Corr. equiv. classes:** [Orphanet:99860](http://www.orpha.net/ORDO/Orphanet_99860), [OMIM:615545](http://purl.obolibrary.org/obo/OMIM_615545), [Orphanet:178554](http://www.orpha.net/ORDO/Orphanet_178554), [Orphanet:544](http://www.orpha.net/ORDO/Orphanet_544), [Orphanet:543](http://www.orpha.net/ORDO/Orphanet_543), [OMIM:113970](http://purl.obolibrary.org/obo/OMIM_113970), 

**Class expressions from DL-Learner:**

- [HP:0001871](http://purl.obolibrary.org/obo/HP_0001871) (Abnormality of blood and blood-forming tissues) and [HP:0011793](http://purl.obolibrary.org/obo/HP_0011793) (Neoplasm by anatomical site) 22.87%
- [HP:0001871](http://purl.obolibrary.org/obo/HP_0001871) (Abnormality of blood and blood-forming tissues) and [HP:0002664](http://purl.obolibrary.org/obo/HP_0002664) (Neoplasm) 22.60%
- [HP:0011793](http://purl.obolibrary.org/obo/HP_0011793) (Neoplasm by anatomical site) 20.19%
- [HP:0002664](http://purl.obolibrary.org/obo/HP_0002664) (Neoplasm) and (not ([HP:0000003](http://purl.obolibrary.org/obo/HP_0000003) (Multicystic kidney dysplasia))) 20.05%
- [HP:0002664](http://purl.obolibrary.org/obo/HP_0002664) (Neoplasm) and (not ([HP:0000011](http://purl.obolibrary.org/obo/HP_0000011) (Neurogenic bladder))) 20.04%
- [HP:0002664](http://purl.obolibrary.org/obo/HP_0002664) (Neoplasm) and (not ([HP:0000016](http://purl.obolibrary.org/obo/HP_0000016) (Urinary retention))) 20.03%
- [HP:0002664](http://purl.obolibrary.org/obo/HP_0002664) (Neoplasm) and (not ([HP:0000013](http://purl.obolibrary.org/obo/HP_0000013) (Hypoplasia of the uterus))) 20.03%
- [HP:0002664](http://purl.obolibrary.org/obo/HP_0002664) (Neoplasm) 20.03%
- [HP:0002664](http://purl.obolibrary.org/obo/HP_0002664) (Neoplasm) and (not ([HP:0000017](http://purl.obolibrary.org/obo/HP_0000017) (Nocturia))) 20.03%
- [HP:0002664](http://purl.obolibrary.org/obo/HP_0002664) (Neoplasm) and (not ([HP:0000012](http://purl.obolibrary.org/obo/HP_0000012) (Urinary urgency))) 20.03%
- [HP:0002664](http://purl.obolibrary.org/obo/HP_0002664) (Neoplasm) and (not ([HP:0000004](http://purl.obolibrary.org/obo/HP_0000004) (null))) 20.03%
- [HP:0001871](http://purl.obolibrary.org/obo/HP_0001871) (Abnormality of blood and blood-forming tissues) 19.58%
- [HP:0000118](http://purl.obolibrary.org/obo/HP_0000118) (Phenotypic abnormality) 17.83%
- Thing 17.83%
- [HP:0000001](http://purl.obolibrary.org/obo/HP_0000001) (All) 17.83%


